Serum High-Sensitivity C-Reactive Protein Levels and the Risk of Atrial Fibrillation in Japanese Population: the Circulatory Risk in Communities Study
Overview
Authors
Affiliations
Aim: This study aimed to investigate the association between the serum high-sensitivity C-reactive protein (hs-CRP) levels and incident atrial fibrillation risk in the general Japanese population, who have lower hs-CRP levels than the Western population, and assess whether the association is modified by sex, overweight, hypertension, and smoking status.
Methods: We conducted a prospective study in 6517 Japanese men and women aged 40-79 years without atrial fibrillation at baseline and enrolled in the Circulatory Risk in Communities Study (2002-2008). The hs-CRP levels were measured using the latex particle-enhanced immunonephelometric assay. Atrial fibrillation was identified using standard 12-lead electrocardiograms and information on physician-diagnosed atrial fibrillation history from the follow-up surveys. We used a Cox proportional hazard regression stratified by community.
Results: During a median follow-up of 11 years, 127 new cases of atrial fibrillation (74 and 53 cases among men and women, respectively) were found. Compared to the lowest quintile of hs-CRP levels, the multivariable hazard ratios (95% confidence intervals) were 2.54 (1.17-5.50), 2.28 (1.06-4.93), 2.92 (1.37-6.23), and 2.77 (1.30-5.91) for the second, third, fourth, and fifth (highest) quintiles, respectively. There was no significant effect modification by sex, overweight, hypertension, and smoking status (P for interaction >0.05).
Conclusions: Elevated hs-CRP levels were significantly associated with increased risk of atrial fibrillation in the Japanese population. The association of hs-CRP levels with incident atrial fibrillation did not vary according to sex, overweight, hypertension status, or smoking status.
Johnston B, Downes M, Hall A, Thomas Z, Welters I PLoS One. 2025; 20(1):e0318365.
PMID: 39879166 PMC: 11778662. DOI: 10.1371/journal.pone.0318365.
Liu Y, Liu H, Sun D, Zheng Y, Tse G, Chen K J Inflamm Res. 2025; 18():91-103.
PMID: 39780989 PMC: 11708200. DOI: 10.2147/JIR.S493068.
Ou G, Zhang Y, Cai H, Yao K, Qiu Z, Chen Y Front Cardiovasc Med. 2024; 11:1446610.
PMID: 39563941 PMC: 11573524. DOI: 10.3389/fcvm.2024.1446610.
Liu Y, He W, Ji Y, Wang Q, Li X BMC Cardiovasc Disord. 2024; 24(1):411.
PMID: 39118024 PMC: 11308650. DOI: 10.1186/s12872-024-04091-8.
Gene Polymorphism and Recurrent Atrial Fibrillation after Catheter Ablation: A Comprehensive Review.
Wang M, Xue C, Shi S, Yang L, Zhu Z, Li J Rev Cardiovasc Med. 2024; 24(4):119.
PMID: 39076272 PMC: 11273024. DOI: 10.31083/j.rcm2404119.